Rink-Jan Lohman

Rink-Jan Lohman is a Senior Research Fellow at the School of Pharmacy and Pharmaceutical Sciences, University of Queensland. With a PhD in Pharmacology from the University of Melbourne, his research spans inflammatory diseases, peptide drug development, and pharmacokinetics. He has contributed extensively to understanding protease-activated receptor-2 (PAR2) modulation and improving oral bioavailability of cyclic peptides.

• Education:
  • Bachelor (Honours) of Science (Advanced), University of Melbourne
  • Doctor of Philosophy, University of Melbourne

Research interests include pharmacology with focus on anti-inflammatory peptides, oral bioavailability optimization, and protease-activated receptor mechanisms. His work on PAR2 antagonists and HDAC inhibitors has implications for arthritis, colitis, and renal disease.

Key article trends reveal expertise in:

• Cyclic peptide design for improved stability
• PAR2 receptor's role in inflammation
• HDAC inhibition for immune modulation
• Opioid receptor targeting without side effects
• Nanocarrier systems for drug delivery

Scientific contributions include grants from:

• NHMRC Project Grant (2015-2017)
• UQ Early Career Researcher Grant (2015)

As an associate advisor, he has supervised PhD projects on:

• Bivalent opioid constructs
• Novel analgesic peptides
• Inflammatory disease drug candidates